Table 5. Summary of demographic characteristics, dose ranges, and duration of studies of Vilazodone.

DB: Double-blinded, RCT: Randomized controlled trial

Studies	Design	Groups (n)	Duration (weeks)	Age (years)	Dose range (mg)
Rickels K, et al., 2009 [37]	RCT	Vilazodone=198	8	18-65	40
		Placebo=199
Khan A, et al., 2011 [38]	RCT	481	8	18-70	40
Boinpally R, et al., 2014 [36]	RCT	Vilazodone and Ketoconazole=37	8	18-60	5-10
		Vilazodone and Carbamazepine=30			40
Croft HA, et al., 2015 [39]	RCT	Vilazodone=253	8	18-70	50
		Placebo=252
Matthews M, et al., 2015 [2]	RCT	Vilazodone 20 mg=292	Single dose	32-76
		Vilazodone 40 mg=291	10	18-70	20-40
		Citalopram 40 mg=289
		Placebo=290
Rele S, et al., 2015 [41]	RCT	Vilazodone 10 mg=20	8	18-65	10-40
		Vilazodone 20 mg=20
		Vilazodone 40 mg=20
Grant JE, et al., 2017 [40]	RCT	Study 1: Citalopram 20 mg=79	12	18-60	40
		Study 2: Citalopram 40 mg=23
		Study 2: Vilazodone 40 mg=19